Label: CLEARASIL ULTRA OVERNIGHT FACE- salicylic acid lotion

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated July 19, 2023

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active Ingredient

    Salicyclic acid 2%

  • Purpose

    Acne Medication

  • Use

    for the treatment of acne

  • Warnings

    For external use only

    When using this product

    • Avoid contact with the eyes. If product gets into the eyes, rinse thoroughly with water
    • With other topical acne medications, at the same time or immediately following use of this product, increased dryness or irritation of the skin may occur. If this occurs, only one acne medication should be used unless directed by your doctor
    • Limit use to the face and neck

    Stop use and ask a doctor ifskin or eye irritation develops.

    Keep out of reach of children.In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

  • Directions

    • Cleanse the skin thoroughly before applying medication
    • Cover the entire affected area with a thin layer one to three times daily
    • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to 2 or 3 applications daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day
  • Other information

    • Store in a cool, dry place
    • Keep outer packaging for precautions and directions
  • Inactive ingredients

    Water, Butylene Glycol, Octyldodecanol, Steareth-2, Cetyl Alcohol, Steareth-21, Dimethicone, Polyacrylamide Glycerin, C13-14 Isoparaffin, Phenoxyethanol, Sodium Hydroxide, Xanthan Gum, Magnesium Aluminum Silicate, Laureth-7, Fragrance, Lavandula Stoechas Extract, Helichrysum Italicum Extract, Cistus Monspeliensis Extract, Methylparaben, Butylparaben, Ethylparaben, Isobutylparaben, Propylparaben, Titanium Dioxide

  • Questions?

    Call 1-866-25-CLEAR (1-866-252-5327).

    You may also report side effects to this phone number.

  • SPL UNCLASSIFIED SECTION

    Distributed by: Reckitt Benckiser LLC
    Parsippany, NJ 07054-0224

  • PRINCIPAL DISPLAY PANEL - 38.4 mL Tube Carton

    Clearasil®

    ULTRA®

    Overnight
    Face Lotion

    Salicylic Acid 2% Acne Medication

    Helps
    visibly reduce
    pimple size
    and redness
    overnight

    1.3 FL. OZ. (38.4 mL)

    PRINCIPAL DISPLAY PANEL - 38.4 mL Tube Carton
  • INGREDIENTS AND APPEARANCE
    CLEARASIL ULTRA  OVERNIGHT FACE
    salicylic acid lotion
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63824-339
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID2 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    OCTYLDODECANOL (UNII: 461N1O614Y)  
    STEARETH-2 (UNII: V56DFE46J5)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    STEARETH-21 (UNII: 53J3F32P58)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    C13-14 ISOPARAFFIN (UNII: E4F12ROE70)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    MAGNESIUM ALUMINUM SILICATE (UNII: 6M3P64V0NC)  
    LAURETH-7 (UNII: Z95S6G8201)  
    LAVANDULA STOECHAS FLOWERING TOP (UNII: 70759G2U6A)  
    HELICHRYSUM ITALICUM FLOWER OIL (UNII: O97ZV7726K)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    BUTYLPARABEN (UNII: 3QPI1U3FV8)  
    ETHYLPARABEN (UNII: 14255EXE39)  
    ISOBUTYLPARABEN (UNII: 0QQJ25X58G)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:63824-339-0138.4 mL in 1 TUBE; Type 0: Not a Combination Product08/18/201109/01/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart333D08/18/201109/01/2024
    Labeler - RB Health (US) LLC (081049410)